Table 2 Clinical, laboratory, echocardiographic and catheter criteria in different types of CHD
From: Angiogenic biomarkers in children with congenital heart disease: possible implications
Patients groups | C-CHD (n = 30) | A-CHD (n = 30) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Studied Parameters | Â | Â | TOF (n = 14) | TGA (n = 9) | DORV (n = 7) | VSD (n = 11) | PS (n = 8) | Aortic coarct (n = 5) | PDA (n = 3) | ASD (n = 3) |
Heart failure (n = 18/60) | 4 | 5 | 3 | 5 | - | 1 | - | - | ||
Cardiomegaly (n = 25/60) | 4 | 4 | 4 | 7 | - | 1 | 3 | 2 | ||
SpO2 (%) | 83 ± 3.6 | 80 ± 2.1 | 82.6 ± 5.4 | 97 ± 1.3 | 96 ± 2.2 | 96.2 ± 3.1 | 97.1 ± 4.8 | 94 ± 3.5 | ||
Hemoglobin (g./dl) | 15 ± 3.3 | 16.2 ± 2 | 16.9 ± 4.3 | 10.5 ± 2 | 10 ± 3.2 | 10.4 ± 3.6 | 11.9 ± 1.8 | 10.8 ± 0.9 | ||
PH (n = 12/60) | - | 5 | 3 | 4 | - | - | - | - | ||
Severe PS (n = 21/60) | 11 | 2 | 3 | - | 5 | - | - | - | ||
Collaterals by echo (n = 11/60) | 5 | 1 | 1 | - | 2 | 2 | - | - | ||
Collaterals by catheter (n = 8/19) | 6 | Not done | Not done | - | Not done | 2 | Not done | Not done | ||